New generation of ADC technology platform under the DCB project support was successfully transferred to the Honeybear Biosciences, which is a company invested by SCI PHARMTECH, the API manufacturer leader in Taiwan.  From left to right in the picture, Chunghsiun Wu, CEO of DCB, Weichyun Wong, Chairman and CEO of SCI PHARMTECH, Chyouhuey Chiou, Director General of Department of Industrial Technology, Ministry of Economic Affairs, ShiingJer Twu, Chairman of DCB, Simon Shih-Hsien Chuang, CEO of Honeybear Biosciences, Chienchen Tai, Senior Technical Specialist of Department of Industrial Technology, Ministry of Economic Affairs